Radoff Bradley Louis 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-17 12:23 pm Purchase |
2025-04-16 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Radoff Bradley Louis | 3,380,100 4.000% |
275,000![]() (+8.86%) |
Filing |
2025-03-21 11:58 am Purchase |
2025-03-20 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Radoff Bradley Louis | 3,105,100 3.600% |
285,100![]() (+10.11%) |
Filing |
2025-03-04 09:27 am Purchase |
2025-02-27 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Radoff Bradley Louis | 2,820,000 3.300% |
2,820,000![]() (New Position) |
Filing |